Lymphocyte-mediated alopecia in C57BL/6 mice following successful immunotherapy for melanoma

Journal of Investigative Dermatology

Volumn 107, Issue 4, 1996, Pages 627-632

  Becker, Jürgen C ^a   Varki, Nissi ^b   Bröcker, Eva Bettina ^c   Reisfeld, Ralph A ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alopecic phenotype; Antibody targeted IL 2; Horizontal transmission; Murine melanoma; Therapy

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRIAMCINOLONE ACETONIDE;

ALOPECIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029846136     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12584237     Document Type: Article

References (39)

1. Argyrus TS: Hair growth induced by damage. Adv Biol Skin 9:339-345, 1967
2. Badri AMTA, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB: An immunohistologic study of cutaneous lymphocytes in vitiligo. J Pathol 170:149-155, 1993
3. Becker JC, Pancook JD, Gillies SD, Furukawa K, Reisfeld RA: T cell mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy. J Exp Med 183:2361-2366, 1996a
4. Becker JC, Pancook JD, Gillies SD, Mendelsohn J, Reisfeld RA: Eradication of human hepatic and pulmonary melanoma metastases in SCID mice by antibody-interleukin 2 fusion proteins. Proc Natl Acad Sci USA 93:2702-2707, 1996b
5. Bucker JC, Varki NM, Gillies SD, Furukawa K, Reisfeld RA: An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response. Proc Natl Acad Sci USA in press, 1996c
6. Billingham RE, Silvers WK: A biologist's reflection on dermatology. J Invest Dermatol 57:227-240, 1971
7. Boon T, Gajewski TF, Coulie PG: From defined human tumor antigens to effective immunization? Immunol Today 16:334-336, 1995
8. Bröcker E-B, Echternacht-Happle K, Hamm H, Happle R: Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 88:564-568, 1987
9. Chen YT, Stocken E, Tsang S, Coplan KA, Old LJ: Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci USA 92:8125-8129, 1995
10. Dranoff G, Mulligan RC: Gene transfer as cancer treatment. Adv Immunol 58:417-454, 1995
11. Elston DM, McCollough ML, Angeloni VL: Vertical and transverse sections of alopecia biopsy specimens: combining the two to maximize diagnostic yield. J Am Acad Dermatol 32:454-457, 1995
12. Gillies SD, Reilly EB, Lo K-M, Reisfeld RA: Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells. Proc Nat Acad Sci USA 89:1428-1432, 1992
13. Haraguchi M, Yamashiro S, Yamamoto A, Furukawa K, Takamiya K, Lloyd KO, Shiku H, Furukawa K: Isolation of GD3 synthase gene by expression cloning of GM3 α-2,8-sialtransferase cDNA using anti-GD2 monoclonal antibody. Proc Natl Acad Sci USA 91:104559-10459, 1994
14. Hardy MH: The secret life of the hair follicle. Trends Genet 8:55-61, 1992
15. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA: Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91:6458-6462, 1994
16. Khoury EL, Price VH, Greenspan JS: HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J Invest Dermatol 90:193-200, 1988
17. Kwon BS: Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family. J Invest Dermatol 100:134S-140S, 1993
18. Lerner AB, Cage GW: Melanomas in horses. Yale J Biol MeJ 46:646-649, 1973
19. Maas RA, Dullens HFJ, Otter WD: IL2 in cancer treatment. Cancer Immunol Immunother 36:141-148, 1993
20. MacDonald-Hull S, Nutbrown M, Pepall L, Thornton MJ, Randall VA, Cunliffe WJ: Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from 'active' and 'normal' areas of alopecia areata. J Invest Dermatol 96:673-681, 1991
21. Messenger AG, Bleehen SS: Alopecia areata: light and electron microscopic pathology of the regrowing white hair. Br J Dermatol 110:155-162, 1984
22. Millikan LE, Hook RR, Manning PJ: Gross and ultrastructural studies in a new melanoma model: the Sinclair swine. Yale J Biol Med 46:631-645, 1973
23. Natali PG, Bigotti A, Nicotra MR, Viora M, Manfredi D, Ferrone S: Distribution of human class I (HLA-A, B, C) histocompatibilty antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 44:4679-4687, 1984
24. Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB: Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol 9:689-696, 1983
25. Pardoll DM: Paracrine cytokine adjuvants in cancer immunotherapy. Annu Rev Immunol 13:399-415, 1995
26. Paul WE, Seder RA: Lymphocyte responses and cytokines. CtH 76:241-251, 1994
27. Paus R, Eichmüller S, Hofmann U, Czarnetzki BM, Robinson P: Expression of classical and non classical MHC class I antigens in murine hair follicles. Br J Dermatol 131:177-183, 1994a
28. Paus R, Handjiski B, Czarnetzki BM, Eichmüller S: A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporine A. J Invest Dermatol 103:143-147, 1994b
29. Paus R, Link RE: The psoriatic epidermal lesion and anagen hair growth may share the same "switch-on" mechanism. Yale J Biol Med 61:467-476, 1988
30. Paus R, Slominski A, Czarnetzki BM: Is alopecia area ta an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 66:541-554, 1994c
31. Richards JM, Mehta N, Ramming K, Skosey P: Sequential chemoimmunotherapy in the treatment of metastatic melanoma. J Clin Oncol 10:1338-1343, 1992
32. Slominski A, Paus R: Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 101:90S-97S, 1993
33. Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N: The role of tyrosinase in autoimmune vitiligo. Lancet 344:1049-1052, 1994
34. Straile WE, Chase HB, Arsenault C: Growth and differentiation of hair follicles between periods of activity and quiescence. J Exp Zool 148:205-216, 1961
35. Sundberg JP, Cordy WR, King LEJ: Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 102:847-856, 1994
36. Tobin DJ, Fenton DA, Kendall MD: Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata. J Invest Dermatol 94:803-807, 1990
37. Wagner JE, Besch-Williford CL, Steffen EK: Health surveillance of laboratory rodents. Lab Anim 20:40-47, 1991
38. Wang RF, Robbins PF, Kawakami Y, Kang XQ, Rosenberg SA: Identification of a gene encoding a melanoma antigen recognized by HLA-A31-restricted tumor infiltrating lymphocytes. J Exp Med 181:799-804, 1995
39. Westgate GE, Craggs RI, Gibson WT: Immune privilege in hair growth. J Invest Dermatol 97:417-420, 1991